🇺🇸 FDA
Patent

US 9822117

Pyridoindolobenz[b,d]azepine derivatives and uses thereof

granted A61PA61P25/02

Quick answer

US patent 9822117 (Pyridoindolobenz[b,d]azepine derivatives and uses thereof) held by DAYA DRUG DISCOVERIES, INC. expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DAYA DRUG DISCOVERIES, INC.
Grant date
Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
51
CPC classes
A61P, A61P25/02